• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Takeda

ESMO 2026
Biotech

From RAS rivalry to leaked readouts, ESMO brought the data drama

Every ESMO conference is eventful, but the drama kicked into gear earlier than expected this year.
James Waldron Oct 27, 2026 8:00am
Takeda booth at AACR 2026

ESMO: Takeda’s $1B bet ‘absolutely’ pays off with ADC ph. 3 win

Oct 23, 2026 9:30am
Illustration for Fierces Chutes  Ladders feature showing a blue city skyline with executives making career moves o

Travere chief makes way for former Amicus CEO—Chutes & Ladders

Sep 25, 2026 8:30am
Illustration for Fierces Chutes  Ladders feature showing a blue city skyline with executives making career moves o

Longtime Takeda R&D chief to depart next June—Chutes & Ladders

Sep 11, 2026 8:30am
Takeda HQ

Takeda’s long-serving R&D chief Andy Plump to retire

Sep 10, 2026 9:25am
Sunlight streaming through window in morning onto alarm clock

The GLP-like race to keep us awake and make billions doing it

Aug 31, 2026 11:24am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings